CHAM
TEVA icon

Clear Harbor Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Clear Harbor Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,000
Closed -$1.56M – 494
2025
Q4 		$1.56M Buy
+50,000
New +$1.23M 0.11% 146

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clear Harbor Asset Management's TEVA Position: Q1 2026 in Review

Clear Harbor Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 3.5% in Q1 2026, selling an estimated $104K and leaving 88,122 shares worth $2.65M. The position accounts for 0.18% of the portfolio, ranked #106.

Clear Harbor Asset Management first reported a position in TEVA in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.85M in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Clear Harbor Asset Management held 88,122 shares of Teva Pharmaceuticals worth $2.65M as of Q1 2026.
  • Clear Harbor Asset Management sold 3,225 Teva Pharmaceuticals shares in Q1 2026, an estimated $104K.
  • Teva Pharmaceuticals made up 0.18% of Clear Harbor Asset Management's portfolio in Q1 2026, its #106 holding.
  • Clear Harbor Asset Management first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
  • Clear Harbor Asset Management's Teva Pharmaceuticals position peaked at $2.85M in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.